Susan Vogt Net Worth
By Isabella Wilson
Susan Vogt biography
Susan Vogt serves as Independent Director of the Company. She served as President and Chief Executive Officer of Aushon Biosystems, Inc., a developer of a multiplex immunoassay platform, from 2013 until the company was acquired by Quanterix Corporation in January 2018. From 2006 to 2011, Ms. Vogt was President and Chief Executive Officer of Seracare Life Sciences, Inc., a Nasdaq-listed life sciences developer of products facilitating human diagnostics and therapeutics. From 1981 to 2005, she served in various officer positions at Millipore Corporation (now part of MillaporeSigma, the life science business of Merck KGaA), an NYSE-listed developer of biotechnology and pharmaceutical drug therapies, including as President of the Biopharmaceutical Division, Vice President and General Manager of the Laboratory Water Division, Vice President and General Manager of the Analytical Products Division, Vice President and General Manager of the Analytical Division, and Finance Manager, Division Controller. Ms. Vogt received her M.B.A. from Boston University with a concentration in Finance and her B.A. from Brown University in Art History.
What is the salary of Susan Vogt?
As the Independent Director of Anika Therapeutics, the total compensation of Susan Vogt at Anika Therapeutics is $184,980. There are 12 executives at Anika Therapeutics getting paid more, with James Loerop having the highest compensation of $1,479,630.
